Theravance Biopharma buy melinda
Start price
03.08.17
/
50%
€28.90
Target price
26.12.17
€37.88
Performance (%)
-13.61%
End price
26.12.17
€24.97
Summary
This prediction ended on 26.12.17 with a price of €24.97. The price of Theravance Biopharma has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.61%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Theravance Biopharma | 0.714% | 0.714% | 55.801% | 38.235% |
| iShares Core DAX® | -1.337% | 1.399% | 2.620% | 51.690% |
| iShares Nasdaq 100 | -2.990% | 2.183% | 33.890% | 89.735% |
| iShares Nikkei 225® | -2.903% | 4.319% | 52.995% | 64.740% |
| iShares S&P 500 | -2.324% | 1.484% | 22.860% | 64.723% |
Comments by melinda for this prediction
In the thread Theravance Biopharma diskutieren
Gesundheit | Biotechnologie | Cayman Islands
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Theravance Biopharma
Theravance Biopharma
Start price
Target price
Perf. (%)
€22.20
11.03.20
11.03.20
€25.00
21.08.20
21.08.20
-29.73%
21.08.20
21.08.20
Theravance Biopharma
Start price
Target price
Perf. (%)
€25.38
10.02.18
10.02.18
€32.11
13.08.18
13.08.18
-0.43%
13.08.18
13.08.18
Theravance Biopharma
Start price
Target price
Perf. (%)
€32.04
03.08.17
03.08.17
€42.00
26.12.17
26.12.17
-13.61%
26.12.17
26.12.17


